NATCO Pharma Limited (NSE:NATCOPHARM)
889.00
+5.50 (0.62%)
Jun 19, 2026, 3:30 PM IST
NATCO Pharma Employees
NATCO Pharma had 4,199 employees as of March 31, 2025. The number of employees increased by 183 or 4.56% compared to the previous year.
Employees
4,199
Change (1Y)
183
Growth (1Y)
4.56%
Revenue / Employee
9.71M INR
Profits / Employee
3.38M INR
Market Cap
159.23B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,199 | 183 | 4.56% |
| Mar 31, 2024 | 4,016 | 70 | 1.77% |
| Mar 31, 2023 | 3,946 | -79 | -1.96% |
| Mar 31, 2022 | 4,025 | -1,021 | -20.23% |
| Mar 31, 2021 | 5,046 | 20 | 0.40% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 16,571 |
| Akums Drugs and Pharmaceuticals | 7,536 |
| Emcure Pharmaceuticals | 6,731 |
| Piramal Pharma | 5,476 |
| Eris Lifesciences | 3,354 |
| Strides Pharma Science | 3,301 |
| Wockhardt | 2,296 |
| Alivus Life Sciences | 2,203 |
NATCO Pharma News
- 3 days ago - Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01% - Business Upturn
- 9 days ago - Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36% - Business Upturn
- 16 days ago - Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79% - Business Upturn
- 17 days ago - Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63% - Business Upturn
- 18 days ago - Lupin And Natco Receive FDA Approval For Eribulin Mesylate Injection - Nasdaq
- 18 days ago - Lupin, Natco Receive FDA Approval For Eribulin Mesylate Injection - Nasdaq
- 18 days ago - Natco Pharma and Lupin secure U.S. FDA approval for Eribulin Mesylate Injection - Business Upturn
- 18 days ago - Pharma sector stocks today, June 3: Natco Pharma falls 2.57%, Zydus Lifesciences falls 1.26%, Alembic Pharma down 1.06% - Business Upturn